Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child

dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorSilva, Paulo Sérgio Lucas da [UNIFESP]
dc.creatorMonteiro Neto, Henrique [UNIFESP]
dc.creatorSejas, Lílian Márcia [UNIFESP]
dc.date.accessioned2015-06-14T13:36:52Z
dc.date.available2015-06-14T13:36:52Z
dc.date.created2015-06-14T13:36:52Z
dc.date.issued2007-04-01
dc.identifierBrazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 11, n. 2, p. 297-299, 2007.
dc.identifier1413-8670
dc.identifierhttp://repositorio.unifesp.br/handle/11600/3670
dc.identifierS1413-86702007000200027.pdf
dc.identifierS1413-86702007000200027
dc.identifier10.1590/S1413-86702007000200027
dc.identifierWOS:000254388400027
dc.description.abstractEnterococci are an uncommon cause of CNS infection. A 20 month-old boy, diagnosed with hydrocephalus with ventriculoperitoneal shunt and history of lengthy hospitalization and use of wide spectrum antibiotics, was admitted to the pediatric intensive care unit diagnosed with ventriculitis. On the 14th day of empirical antibiotic therapy (vancomycin and meropenem) the child presented fever while the CSF sample culture evidenced vancomycin-resistant Enterococcus faecium. The patient received intravenous linezolid achieving cerebrospinal fluid sterilization. Conclusion: Intravenous linezolid appears to be a safe and effective therapy for vancomycin-resistant enterococcus ventriculoperitoneal shunt infection.
dc.languageeng
dc.publisherBrazilian Society of Infectious Diseases
dc.relationBrazilian Journal of Infectious Diseases
dc.rightsAcesso aberto
dc.subjectVancomycin
dc.subjectresistance
dc.subjecttreatment
dc.titleSuccessful treatment of vancomycin-resistant enterococcus ventriculitis in a child
dc.typeArtigo


Este ítem pertenece a la siguiente institución